Tumor tissue via thermal coagulative necrosis

Tumor tissue via thermal coagulative necrosis refers to a therapeutic outcome or physiological state rather than a specific molecular target like a receptor or enzyme. This process is the fundamental mechanism behind thermal ablation techniques, such as radiofrequency ablation (RFA), microwave ablation (MWA), and high-intensity focused ultrasound (HIFU) (StatPearls, NBK499908). When tumor tissue is subjected to temperatures exceeding 55-60°C, cellular proteins undergo rapid denaturation and lipid membranes are disrupted, resulting in immediate and irreversible cell death known as coagulative necrosis (PubMed, 10527730). While not a drug target in the traditional sense, this state is the objective of various interventional oncology procedures used to treat solid tumors in the liver, lung, and kidney. The efficacy of this process is typically monitored via radiological imaging to ensure a complete kill zone with adequate margins. Safety concerns are primarily related to the physical application of heat, including potential damage to adjacent healthy structures or the heat-sink effect from nearby blood vessels (PubMed, 25633681).

Other names

Thermal ablationCoagulative necrosisHyperthermic cell deathImage-guided thermal ablation

The mechanism involves the application of thermal energy to induce temperatures above 55-60°C, leading to the instantaneous denaturation of intracellular proteins and the collapse of cellular membranes, which results in irreversible coagulative necrosis (StatPearls, NBK499908).